Astex Pharmaceuticals has been celebrating a very successful first 25 years following a visit from Science minister Patrick ...

News Corp’s revenue and profit increased in its fiscal second quarter, reflecting gains at its Dow Jones, digital real estate ...

Hiring in the U.S. labor market is slowing down, leading to lower demand for payroll, human resources management and other products offered by companies such as Dayforce. U.S. job openings fell by the ...

The tech giant's fast-growing cloud-computing business decelerated last quarter. Some analysts said tougher comparisons, harsher weather and holiday timing may have put pressure on the fast-casual ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Initiation of Phase 1/2 combination trial with PYX-201, an extracellular ADC targeting Extradomain-B Fibronectin (EDB+FN) and Merck’s KEYTRUDA® ...

In a strongly worded letter, Caroline Kennedy urged the Senate to reject Robert F. Kennedy Jr. for the role of Health and ...

RFK Jr. played a lead role in building a case against Merck's HPV vaccine and could profit from the lawsuit alleging fraud, even if confirmed as health secretary.

TotalEnergies will provide STMicroelectronics with the renewable power (including the guarantee of origin) produced by two recent wind and solar farms of 75 MW operated by TotalEnergies. This power ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC's Squawk on the ...

Merck (NSE:PROR ... won't close the remaining interest in EnLink until the first quarter of this year. Because of that timing, the company will get most of the benefit of those deals this ...